頭頸部癌に対するホウ素中性子捕捉療法―当施設での歩み―

DOI Web Site Web Site 参考文献16件

書誌事項

タイトル別名
  • BNCT for Head and Neck Cancer—History at Our Institution—
  • アタマ ケイブガン ニ タイスル ホウソ チュウセイシ ホソク リョウホウ : トウ シセツ デ ノ アユミ

この論文をさがす

抄録

<p>PURPOSE: Boron neutron capture therapy (BNCT) is among the radiation treatments known to have a selective lethal effect on tumor cells. In this report, we summarize our clinical results for BNCT for the treatment of head and neck cancer at our institution.</p><p>METHODS: We started clinical studies for the treatment of head and neck cancer in 2003. Since then, we have completed the following four clinical studies: (1) an analysis of the accumulation of BPA in the tumor and surrounding normal tissue using an 18FBPA-PET study, (2) a BNCT clinical trial for recurrent head and neck cancer, (3) a BNCT clinical trial for head and neck melanoma, and (4) a BNCT clinical trial for newly diagnosed advanced head and neck cancer. All the patients provided consent, and the study was approved by the medical ethics committees of Kawasaki Medical School and Kyoto University. BNCT was performed in a single fraction using an epithermal beam at the Kyoto University Research Reactor and the Japan Research Reactor 4.</p><p>RESULTS: The 18FBPA-PET study showed no difference in the T/N ratio between an SCC and a non-SCC group. Overall, 83% of the patients had a T/N ratio of more than 2.5. The response rates were more than 80% for all the BNCT clinical studies. Although mild alopecia, xerostomia, and fatigue were observed in all the patients, no severe adverse effects of grade 3 or higher occurred in these patient series.</p><p>CONCLUSIONS: Our preliminary results demonstrated that BNCT is a potentially curative therapy for patients with head and neck cancer. The treatment does not cause any serious adverse effects and can be used regardless of whether the primary tumor has been previously treated.</p>

収録刊行物

参考文献 (16)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ